Chicago White Sox v Cleveland Indians

2014 Preview: Chicago White Sox

13 Comments

Between now and Opening Day, HardballTalk will take a look at each of baseball’s 30 teams, asking the key questions, the not-so-key questions, and generally breaking down their chances for the 2014 season. Next up: The Chicago White Sox.

The Big Question: Can the White Sox rebuild the league’s worst lineup on the fly?

Chicago went from 85 wins in 2012 to 63 wins last year for the White Sox’s worst season since 1970. Their pitching got worse, but it was nothing compared to the offense falling off a cliff by going from fourth in the league with 748 runs to dead last with 598 runs. It was ugly.

Instead of stocking up on prospects with an eye toward several years down the road general manager Rick Hahn has instead tried to rebuild the lineup in the short and long term, acquiring MLB-ready young talent in Jose Abreu, Adam Eaton, Matt Davidson, and Avisail Garcia. In doing so he traded away a young closer in Addison Reed and a young mid-rotation starter in Hector Santiago, and the White Sox previously parted with Jake Peavy, Alex Rios, Jesse Crain, and Matt Thornton in the middle of last season. Toss in Paul Konerko fading into a part-time role and this is a very different lineup than the .680 OPS crew, but will the results be much different?

Not so long ago Eaton looked like one of the best leadoff prospects in baseball, Abreu has immense upside after putting up monster numbers as a slugger in Cuba, and both Davidson and Garcia have the potential to be solid contributors offensively. But for the White Sox’s lineup to go from horrible to respectable immediately they need just about everything to click and holdover bats Gordon Beckham, Alexei Ramirez, Dayan Viciedo, and Tyler Flowers have disappointed after once showing promise as youngsters themselves.

Chicago’s offense can’t help but be better in 2014, but the White Sox don’t look capable of making the leap into contention and the success or failure of the season depends largely on Abreu living up to the hype and 2-3 other young bats emerging as long-term regulars (plus Chris Sale staying healthy and remaining one of the elite starters in the league, of course). If they can accomplish those things and win 70-something games Hahn and company should be pretty happy with the offseason moves.

What else is going on?

  • Thanks to a misleadingly poor win-loss record last season it’s possible that a lot of people don’t realize just how amazing Sale has been as a starter. Among all MLB starting pitchers since 2012–when he moved into the rotation–Sale ranks ninth in ERA and third in ERA+, which adjusts for ballparks and leagues. He’s also fifth in strikeout rate, fourth in K/BB ratio, and ninth in opponents’ OPS. He’s one of the best 5-10 pitchers in baseball and he’s still just 25 years old.
  • Much is being made about the decision to trade away a 24-year-old closer coming off a 40-save season, but Reed wasn’t all that great once you get past the save total. He has a 4.17 career ERA, is more fly-ball prone that is ideal in the ninth-inning role, and has mediocre control. And while he’s piled up plenty of saves his actual save conversion rate of 85 percent is nothing special. The wisdom of the trade obviously depends on whether Davidson proves to be a valuable regular, but the idea of cashing in Reed was a smart one. Closers are made, not born, and Nate Jones or Matt Lindstrom likely can handle the job without much dropoff.
  • Exactly how good can Abreu be? Projecting foreign players is always tough, but Fan Graphs’ reliable ZiPS system pegs Abreu as a .273 hitter with 26 homers and an .858 OPS as a rookie. To put that in some context, an .858 OPS would have ranked sixth among MLB first basemen last season, one spot behind Freddie Freeman. If the White Sox get that, they should be thrilled with their $68 million investment. (The bad news? Abreu is the only White Sox hitter projected by ZiPS to be above average.)
  • Overshadowed by the young, MLB-ready bats brought into the mix is that the White Sox also already had a very good infield prospect in Marcus Semien. Last season between Double-A and Triple-A he hit .284 with 19 homers, 24 steals, more walks (98) than strikeouts (90), and an .880 OPS, including a studly .401 on-base percentage at age 22. Semien getting on base and Abreu knocking him in could be a very nice combo for a long time, perhaps as soon as midseason.

Prediction: Better–and a whole lot more interesting–but still nowhere near good. Fifth place, AL Central.

Dee Gordon’s suspension is likely to lead to a call for harsher PED penalties

Miami Marlins' Dee Gordon celebrates after hitting a double against the Detroit Tigers in the ninth inning of a baseball game Tuesday, April 5, 2016, in Miami. Derek Dietrich scored on the double. The Tigers won 8-7. (AP Photo/Alan Diaz)
Associated Press
19 Comments

Objectively speaking there is no difference between Dee Gordon’s suspension for PEDs and anyone else’s. Abraham Almonte, for example. Or Cameron Maybin. Or David Rollins. All were guys who got their 80 games, served their time, came back and whose cases didn’t raise too much of a fuss. But Gordon’s suspension will almost certainly be talked about longer and more loudly and will likely lead to calls for harsher penalties and changes to the PED suspension rules.

Part of it is simply fame. He’s a pretty big name as far as these things go. The biggest since the Biogenesis guys a couple of years ago. He won the batting title last year. He’s the son of a famous major leaguer. There is a direct correlation between the volume and intensity of the narratives applied to one’s story and the fame of the subject of the story. For that reason alone Gordon’s story will last longer and loom larger.

Another reason — a bigger reason, I think — is timing. Gordon was seen by many to have had a breakout season in 2015 and, when it was over, he was rewarded for it with a nice five-year $50 million deal. The narrative will arise by, oh, 9AM today, that the suspension was “worth it” for Gordon and that he cashed in because of it, rendering his suspension a mere slap on the wrist. This is especially true given that his deal is severely backloaded. He’ll lose less than $2 million in salary in 2016 while collecting the other $48 million-plus. Totally worth it!

I understand why people will say that, but such a stance has some serious flaws. Among them:

  • It assumes that we or anyone else knows when Gordon began to take PEDs;
  • It assumes that we or anyone else knows how, in fact, Gordon’s performance was actually enhanced;
  • It forgets that lots and lots of people were talking about how Gordon’s “breakout season” was actually 2014, not 2015, rendering that whole “he juiced and then got his money” argument fairly problematic.

Those points will likely be ignored as arguments in favor of harsher penalties grow louder. Ken Rosenthal reminds us this morning that some have called for some form of contract voiding or clawing back of more money than just the salary earned while on suspension. Those calls too will likely grow louder. There will also be calls for changes in the appeal process. Like this one, which came moments after Gordon’s suspension was announced:

When you have an actual union member angrily call for the repeal of a collectively-bargained protection in punishment situations, you’re sort of through the looking glass. Or past a tipping point. Or something. You’re certainly in a world where the usual dynamics between employer and employee are not operative and, as a result, changes are inevitable. As we noted recently, players today are perhaps more adamantly anti-PED than the owners and the league are. They’re competitors reacting to cheating by their competition. The fuel for stronger penalties is likely to come more from them than anyone.

The union and the league will be negotiating a new Collective Bargaining Agreement this year. Performance enhancing drugs and their penalties will be a part of that. Expect harsher penalties and possibly different sorts of rules altogether. Expect Dee Gordon to be the poster child for these changes, even if his case is no different in form than that of Abraham Almonte, Cameron Maybin, or David Rollins. Expect emotion, rather than logic, to lead the coming debate.

And That Happened: Thursdays scores and highlights

Atlanta Braves relief pitcher Arodys Vizcaino, right, is congratulated by catcher Tyler Flowers after earning a save during a baseball game against the Boston Red Sox at Fenway Park in Boston, Thursday, April 28, 2016. The Braves defeated the Red Sox 5-3. (AP Photo/Charles Krupa)
5 Comments

Gonna mail this one in this morning. Partially because of the light slate of games yesterday, partially because of a late night for me but mostly because of the Dee Gordon news which has me thinking of a lot of other things I want to write about this AM.

It’s worth noting that the Braves won a game. It comes just ahead of a series at Wrigley against the Cubs, so the winning streak will likely last a single day, but the 2016 Braves have to take what they can get.

The Marlins had a notable night outside the Gordon news too, finishing off a sweep of the Dodgers, which had to make Don Mattingly happy. For what it’s worth, Gordon singled in a run and then came around to score in the seventh. His RBI tied it and the run he scored ended up being the one necessary for the Marlins’ margin of victory. That means nothing, but you know some jackwagons are gonna make a big deal out of that and I figured I’d get ahead of the jackwagons and note that, yes, Gordon and the Marlins knew what was coming before it was announced because that’s how the appeals process works, but no, it makes no difference, because that’s how the appeals process works.

Anyway: Here are the rest of the scores:

Tigers 7, Athletics 3
Cubs 7, Brewers 2
Phillies 3, Nationals 0
Orioles 10, White Sox 2
Braves 5, Red Sox 3
Diamondbacks 3, Cardinals 0
Marlins 5, Dodgers 3
Pirates vs. Rockies — POSTPONED
: In the early morning rain with a dollar in my hand. And an aching in my heart, and my pockets full of sand. I’m a long way from home, and I miss my loved one so. In the early morning rain with no place to go.

Marlins 2B Dee Gordon suspended 80 games for PEDs

deegordon
Getty Images
37 Comments

LOS ANGELES — Dee Gordon has been suspended 80 games by Major League Baseball after the Miami Marlins second baseman tested positive for a performance-enhancing drug.

Gordon tested positive for exogenous Testosterone and Clostebol, MLB said in a release after the Marlins’ 5-3 victory over the Los Angeles Dodgers on Thursday night.

The fleet-footed Gordon won the National League batting title by hitting .333 last season and signed a $50 million, 5-year deal with Miami in January. He’s made two All-Star teams in his six seasons and won the Gold Glove and Silver Slugger awards at second base last year.

Gordon, the son of former major league pitcher Tom Gordon, had a key hit in Miami’s win over the Dodgers on Thursday. He’s batting .266 with six stolen bases this season.

Dee Gordon is a very important part of our team, and we all love him and support him,” Marlins president David Samson said. “That said, I don’t like or condone what he did. He is an important member of this organization and will be for many years to come. It’s a huge, huge disappointment to the kids, to our fans, to his teammates and to everyone in our organization every single day.

“He will be back 80 games from now, and he will be welcomed back to this organization. But in the interim period, we expect him, and we are positive that he will do everything that’s necessary to make it up to his fans, to his teammates and to this organization.”

Devon Travis will start taking at-bats in extended spring training

Toronto Blue Jays second baseman Devon Travis hits a RBI double to center field against the Tampa Bay Rays during third inning of a baseball game, Wednesday, April 15, 2015 in Toronto. (Nathan Denette/The Canadian Press via AP)  MANDATORY CREDIT
Nathan Denette/The Canadian Press via AP
4 Comments

Blue Jays second baseman Devon Travis underwent left shoulder surgery last September. MLB.com’s Gregor Chisholm caught up with Jays head athletic trainer George Poulis for updates on several injured players, including Travis. Here’s what Poulis had to say about Travis:

“He’s going to get some live at-bats with the extended team down in Florida on Friday. Big step for him, he’s very excited, he’s doing great, and we’re very optimistic, but no timeline right now on his return. We’re just going day by day, step by step.

“When you have something like that, it continues to heal even when you’re playing. We’re just trying to acclimate him and condition him to withstand all of the stress that he’s going to put on his shoulder … He won’t play in the field right now. We’ll mix that in, as well, but right now he’s just going to get some at-bats.”

The key phrase, of course, is “no timetable”. The second baseman’s rehab has gone slower than expected. Getting into some extended spring training games, though, signals progress.

Travis, 25, broke out last season, hitting .304/.361/.498 with eight home runs and 35 RBI in 239 plate appearances last season. The Jays have had Ryan Goins and Darwin Barney handle second base duties this year, but their aggregate .560 OPS is the worst mark in the American League.